Twist Bioscience Corp (TWST) rating initates by Wolfe Research

Twist Bioscience Corp’s recently made public that its Chief Financial Officer Laponis Adam unloaded Company’s shares for reported $93420.0 on Jul 09 ’25. In the deal valued at $38.15 per share,2,449 shares were sold. As a result of this transaction, Laponis Adam now holds 103,569 shares worth roughly $3.94 million.

Then, Laponis Adam bought 2,449 shares, generating $93,419 in total proceeds.

Before that, Cho Dennis sold 125 shares. Twist Bioscience Corp shares valued at $4,524 were divested by the insider at a price of $36.19 per share. As a result of the transaction, Cho Dennis now holds 104,612 shares, worth roughly $3.98 million.

Wolfe Research initiated its Twist Bioscience Corp [TWST] rating to an Outperform in a research note published on December 13, 2024; the price target was $60. A number of analysts have revised their coverage, including Guggenheim’s analysts, who began to cover the stock in early June with a ‘”a Buy”‘ rating. Goldman also remained covering TWST and has increased its forecast on January 17, 2024 with a “Buy” recommendation from previously “Neutral” rating. Berenberg started covering the stock on September 27, 2023. It rated TWST as “a Buy”.

Price Performance Review of TWST

On Friday, Twist Bioscience Corp [NASDAQ:TWST] saw its stock fall -1.14% to $38.03. Over the last five days, the stock has lost -0.37%. Twist Bioscience Corp shares have fallen nearly -24.69% since the year began. Nevertheless, the stocks have fallen -18.16% over the past one year. While a 52-week high of $60.90 was reached on 01/24/25, a 52-week low of $27.12 was recorded on 05/23/25.

Levels Of Support And Resistance For TWST Stock

The 24-hour chart illustrates a support level at 37.43, which if violated will result in even more drops to 36.83. On the upside, there is a resistance level at 38.45. A further resistance level may holdings at 38.86.

How much short interest is there in Twist Bioscience Corp?

A steep rise in short interest was recorded in Twist Bioscience Corp stocks on 2025-06-13, dropping by -0.31 million shares to a total of 10.31 million shares. Yahoo Finance data shows the prior-month short interest on 2025-05-15 was 10.62 million shares. There was a decline of -2.98%, which implies that there is a negative sentiment for the stock.

The most recent change occurred on January 05, 2023 when Scotiabank began covering the stock and recommended ‘”a Sector outperform”‘ rating along with a $33 price target.

Most Popular

Knox Daily
Privacy Overview

This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.